Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy of Ustekinumab in Crohn's Disease: an Observational Study With Retrospective and Prospective Components

NCT06523647 is registered in ClinicalTrials.gov with Kazakhstan Scientific Society for Study of intestine diseases as lead sponsor.

NCT NCT06523647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06523647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy of Ustekinumab in Crohn's Disease: an Observational Study With Retrospective and Prospective Components
Lead sponsor
Kazakhstan Scientific Society for Study of intestine diseases
Phase
Observational
Overall status
Unknown status
Start date
June 27, 2023
Completion date
December 31, 2025
Enrollment
150 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease